
Global Blood Therapeutics GBT
Quarterly report 2022-Q2
added 08-08-2022
Global Blood Therapeutics Total Inventories 2011-2026 | GBT
Annual Total Inventories Global Blood Therapeutics
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 58.2 M | 40.2 M | 1.28 M | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 58.2 M | 1.28 M | 33.2 M |
Quarterly Total Inventories Global Blood Therapeutics
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | 65.8 M | 62 M | 58.2 M | 51.5 M | 48 M | 42.3 M | 40.2 M | 40.2 M | 40.2 M | 40.2 M | 1.28 M | 1.28 M | 1.28 M | 1.28 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 65.8 M | 1.28 M | 35.3 M |
Total Inventories of other stocks in the Biotechnology industry
| Issuer | Total Inventories | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Aptorum Group Limited
APM
|
39.1 K | $ 0.88 | - | $ 6.47 M | ||
|
ACADIA Pharmaceuticals
ACAD
|
91.7 M | $ 22.56 | -0.49 % | $ 3.74 B | ||
|
BioDelivery Sciences International
BDSI
|
23.7 M | - | -4.8 % | $ 255 M | ||
|
Aquestive Therapeutics
AQST
|
6.17 M | $ 4.1 | 0.12 % | $ 438 M | ||
|
Arcutis Biotherapeutics
ARQT
|
22.6 M | $ 23.01 | -1.2 % | $ 2.93 B | ||
|
Autolus Therapeutics plc
AUTL
|
33.2 M | $ 1.43 | -3.38 % | $ 381 M | ||
|
BeiGene, Ltd.
BGNE
|
608 M | - | 0.49 % | $ 251 B | ||
|
bluebird bio
BLUE
|
22.9 M | - | - | $ 546 M | ||
|
Cara Therapeutics
CARA
|
2.82 M | - | -3.03 % | $ 260 M | ||
|
CASI Pharmaceuticals
CASI
|
1.91 M | - | - | $ 35.4 M | ||
|
BioXcel Therapeutics
BTAI
|
722 K | $ 1.04 | -1.56 % | $ 12.7 M | ||
|
ChemoCentryx
CCXI
|
851 K | - | - | $ 3.74 B |